Atypical antipsychotics in severe anorexia nervosa in children and adolescents—review and case reports

✍ Scribed by Claudia Mehler-Wex; Marcel Romanos; Julia Kirchheiner; Ulrike M.E. Schulze

• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 149 KB
• Volume: 16
• Category: Article
• ISSN: 1072-4133
• DOI: 10.1002/erv.843

✦ Synopsis

Abstract

Objective

To review the literature on the use of atypical antipsychotics in anorexia nervosa of children and adolescents and to present three case reports on quetiapine treatment of this subgroup.

Method

Review of the literature and case report.

Results

Several case reports and two small open‐label trials, mainly in adults, observed beneficial effects of olanzapine on anorexic psychopathology. Only 16 case reports have been published on children and adolescents. Because of its lower propensity to induce weight gain quetiapine might be favourable with regard to patients' compliance. Our case reports revealed positive psychopathological effects and good tolerability of quetiapine in minors with severe anorexia nervosa. Careful titration and intense drug monitoring are recommended.

Discussion

In a small subset of patients with severe, treatment‐ resistant anorexia nervosa, extreme weight phobia, delusional body image disturbances or severe hyperactivity might be considered as indications for atypical antipsychotics. However, controlled studies are needed. Copyright © 2007 John Wiley & Sons, Ltd and Eating Disorders Association.